expert roundtables

Optimizing the Care of Patients With Nonmetastatic Castration-Resistant Prostate Cancer

by Peter R. Carroll, MD, MPH; William K. Oh, MD; and Oliver Sartor, MD

The optimal monitoring of patients with nonmetastatic (M0 or nm) castration-resistant prostate cancer (CRPC), who may be on androgen receptor (AR)–......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles